Table 6.
Pre-diagnosis (antibiotic[s]) |
Post-diagnosis (antibiotic[s]) |
No. of cats (n = 37) |
Outcome (n = 37) |
Remarks | |
---|---|---|---|---|---|
1 | Amoxicillin–clavulanic acid | – | 3 | 3 died | One owner refused boarding; 2 died in pre-diagnostic management |
2 | Amoxicillin–clavulanic acid | Azithromycin + rifampin | 3 | 2 recovered, 1 died |
Of 2 recovered cats, 1 went through a course of enrofloxacin + azithromycin before presentation. Other bacteria were susceptible to azithromycin, but infection relapsed after apparent recovery of this cat, possibly because of poor compliance, and the cat died 9 weeks after initial diagnosis because of a similar presentation |
3 | Marbofloxacin | – | 2 | 1 recovered, 1 died |
One cat died in pre-diagonstic management, while the other went through thoracotomy, and bacteria susceptible to marbofloxacin |
4 | Marbofloxacin | Azithromycin | 1 | 1 died | Went through thoracotomy but died within 7 days of postoperative management of infection |
5 | – | Gentamicin + rifampin | 1 | 1 euthanased | Owner refused post-diagnosis management |
6 | Marbofloxacin + metronidazole | – | 3 | 3 died | Two cats died during pre-diagnostic management; third cat died during long-term (4 weeks) management post-diagnosis |
7 | Marbofloxacin + metronidazole | Switched to azithromycin + rifampin | 1 | 1 recovered | Bacteria susceptible to azithromycin |
8 | Amoxicillin–clavulanic acid + metronidazole | Switched to azithromycin + rifampin | 8 | 5 recovered, 2 died, 1 euthanased |
Of the two cats that died, 1 was FeLV positive. Infection relapsed after an apparently full recovery in 1/5 recovered cats, possibly because of poor compliance, and the cat died 10 weeks after the initial diagnosis because of a similar presentation |
9 | Amoxicillin–clavulanic acid + metronidazole | Switched to marbofloxacin + rifampin | 2 | 2 recovered | Bacteria was susceptible to marbofloxacin in both cases |
10 | Amoxicillin–clavulanic acid + metronidazole | – | 4 | 4 died | All cats died during pre-diagnostic management of infection |
11 | Amoxicillin–clavulanic acid + azithromycin | Rifampin added and amoxicillin–clavulanic acid stopped | 1 | 1 euthanased | Poor response to treatment during long-term management (4 weeks) |
12 | Amoxicillin–clavulanic acid + metronidazole + azithromycin | Rifampin added and amoxicillin–clavulanic acid and metronidazole stopped | 2 | 1 recovered, 1 died |
Dead cat had a high FCoV antibody titre and a low A:G (0.5), supporting clinical signs |
13 | Amoxicillin–clavulanic acid + marbofloxacin + azithromycin | Rifampin added and amoxicillin–clavulanic acid stopped | 1 | 1 recovered | – |
14 | Amoxicillin–clavulanic acid + metronidazole + marbofloxacin | Rifampin added and amoxicillin–clavulanic acid and metronidazole stopped | 2 | 1 recovered, 1 died |
Poor response to antibiotics seen in the dead cat and bacteria were resistant to marbofloxacin |
15 | Amoxicillin–clavulanic acid + metronidazole + marbofloxacin | Switched to azithromycin and rifampin | 1 | 1 euthanased | Poor response to antibiotics and chest tube management, although bacteria were susceptible to azithromycin |
16 | Amoxicillin–clavulanic acid + metronidazole + marbofloxacin | – | 1 | 1 recovered | Eight weeks of therapy and bacteria were susceptible to marbofloxacin |
17 | Amoxicillin–clavulanic acid + metronidazole + enrofloxacin | – | 1 | 1 died | Died during pre-diagnostic management |
Amoxicillin–clavulanic acid: 12.5–20 mg/kg q12h; metronidazole: 10–15 mg/kg (lower dosage q8h and higher dosage q12h); marbofloxacin: 2–4 mg/kg q24h (higher dosage for susceptible bacteria); enrofloxacin: 5 mg/kg q24h for a maximum of 3 days; azithromycin: 10 mg/kg q24h used for a maximum of 8 weeks; rifampin: 10 mg/kg q24h used for a maximum of 8 weeks (with on and off adverse effects in three cases, such as anorexia and vomiting possibly related to hepatotoxicity)
FeLV = feline leukaemia virus; FCoV = feline coronavirus; A:G = albumin to globulin ratio